Domeboro® website is now live
Moberg Pharma North America launches a new website for Domeboro® - www.Domebororelief.com
In addition to product information, www.Domobororelief.com also contains a Skin Care Center with information on common causes and treatment of rashes and skin irritations. For over 50 years, Domeboro® has provided an effective treatment for relieving minor skin irritations due to poison ivy, poison oak, poison sumac, insect bites, athlete's foot, or rashes caused by soaps, detergents, cosmetics, or jewelry. Domeboro® is available at major drugstores, food and mass retailers as well as online retailers in the U.S.
About Moberg Pharma
Moberg Pharma AB (publ) is a rapidly growing Swedish pharmaceutical company with a direct sales and marketing organization in the U.S. and an extensive distributor network in more than 40 countries. The company’s OTC portfolio includes the brands Kerasal®, Jointflex®, Kerasal Nail™, Domeboro®, Vanquish®, and Fergon®. Kerasal Nail™ (Nalox™ in certain ex-U.S. markets) is the leading product for the treatment of nail disorders in the U.S. and Nordic market. The current portfolio will be supplemented by the acquisition and in-licensing of additional products as well as product development with a focus on innovative drug delivery of proven compounds. Moberg Pharma has offices in Stockholm and New Jersey and the company’s shares (OMX: MOB) are listed on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm. For further information, please visit: www.mobergpharma.com.